Actively Recruiting
Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial
Led by Shanghai Institute of Acupuncture, Moxibustion and Meridian · Updated on 2026-04-13
106
Participants Needed
1
Research Sites
228 weeks
Total Duration
On this page
Sponsors
S
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Lead Sponsor
R
Ruijin Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study was to further improve the clinical efficacy of acupuncture in delaying the clinical recurrence of CD and to explore the efficacy mechanism of acupuncture efficacy enhancement.
CONDITIONS
Official Title
Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a clinical diagnosis consistent with Crohn's Disease
- Aged between 16 and 75 years
- Currently in remission (CDAI < 150 and CRP < 5mg/l, or Faecal calprotectin < 50µg/g, or no ulcer under endoscopy)
- Have had two or more disease recurrences in past years
- Not taking medication or only taking mesalazine (≤4g/d), prednisone (≤15mg/d), azathioprine (≤1mg/kg/d) for specified minimum durations or have poor response or loss of response to biological therapies
- Have never received acupuncture
- Signed informed consent
You will not qualify if you...
- Currently pregnant, recently pregnant, or breastfeeding
- Have serious organic diseases
- Diagnosed with psychosis
- Have multiple diseases requiring long-term medication that may affect study results
- Have severe skin diseases (e.g., erythema nodosum, pyoderma gangrenosum), eye diseases (e.g., iritis, uveitis), thromboembolic diseases, or serious extraintestinal manifestations
- Have serious intestinal complications such as fistula, abscess, stenosis, obstruction, perforation, hemorrhage, or perianal abscess
- Have short bowel syndrome or had abdominal/gastrointestinal surgery within the past 6 months
- Have skin diseases or defects in the areas selected for acupuncture and moxibustion that prevent treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Research Institute of Acupuncture and Meridian
Shanghai, China
Actively Recruiting
Research Team
B
Bao Chunhui, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here